Literature DB >> 2650206

Long-term survival of kidney grafts.

P Terasaki1, M R Mickey, Y Iwaki, J Cicciarelli, M Cecka, D Cook, J Yuge.   

Abstract

1. In the long-term period, the half-life effectively measured loss rate. For HLA-identical sib donors the half-life was 25 years; for parental donors, 13 years; and for cadaver donors, 8 years (now possibly 11 years). 2. HLA-A,B,DR matching exerted the greatest effect on half-life, for a half-life of 17 years was achieved for cadaver donors. This rate was not quite as high as that for A,B,DR matched siblings but was higher than the one haplotype mismatched parental donor transplants. 3. Caucasian recipients had a half-life of 8 years compared to 5 years for black recipients. 4. Excellent centers had a 10-year half-life compared to 5 years for fair centers. 5. Cold ischemia time over 24 hours, recipient age over 55, and donor age of 50-60 had a small effect on the half-life in the order of 1 to 3 years. 6. Among the short-term factors that affect the 1-year graft survival, there was a 12% difference between excellent and fair centers. An 11% difference between A,B,DR matched transplants and 6 A,B,DR mismatched grafts was noted. First-cadaver donor grafts had a 10% higher graft survival at 1-year than second grafts. Other factors together with the difference in 1-year graft survival between the extremes were as follows: sensitization 9%, race 8%, transfusion 6%, donor age 6%, diabetic 3%, recipient age 3% and cold ischemia 1%. Thus more factors affect short-term survival than long-term survival.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2650206

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  4 in total

Review 1.  Management of allosensitized cardiac transplant candidates.

Authors:  Mauricio Velez; Maryl R Johnson
Journal:  Transplant Rev (Orlando)       Date:  2009-10       Impact factor: 3.943

2.  Allografts surviving for 26 to 29 years following living-related kidney transplantation: analysis by light microscopy, in situ hybridization for the Y chromosome, and anti-HLA antibodies.

Authors:  P S Randhawa; T Starzl; H C Ramos; M A Nalesnik; J Demetris
Journal:  Am J Kidney Dis       Date:  1994-07       Impact factor: 8.860

3.  Arteriolosclerosis of the human renal allograft: morphology, origin, life history and relationship to cyclosporine therapy.

Authors:  P Rossmann; J Jirka; M Chadimová; I Reneltová; F Saudek
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Twenty-five years of renal transplantation from a single center: a risk factor analysis for short- and long-term outcomes.

Authors:  H H Neumayer; F C Luft
Journal:  Clin Investig       Date:  1993-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.